Veradermics, Inc. (MANE)
99.92
-0.46
(-0.46%)
USD |
NYSE |
May 19, 16:00
99.92
0.00 (0.00%)
After-Hours: 18:07
Veradermics Research and Development Expense (Quarterly) : 20.92M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Organon & Co. | 93.00M |
| Merck & Co., Inc. | 11.98B |
| Bristol Myers Squibb Co. | 2.238B |
| Terns Pharmaceuticals, Inc. (DELISTED) | 18.90M |
| Corcept Therapeutics, Inc. | 66.26M |